Serine/threonine-protein kinase PAK 5

Description:

Description
  • Accession: Q9P286
  • Swissprot: PAK5_HUMAN
  • Organism: Homo sapiens
  • Gene: PAK5
  • Target class: Kinase

Drug Relations:

nintedanib
Boehringer Ingelheim's triple kinase inhibitor blocking VEGFR, PDGFR and FGFR Bioactivity details MOA
ruxolitinib
a kinase inhibitor, inhibits Janus Associated Kinases (JAKs) JAK1 and JAK2 which mediate the signaling of a number of cytokines and growth factors that are important for hematopoiesis and immune function Bioactivity details MOA
sunitinib
inhibits VEGF-R2 and PDGF-Rbeta tyrosine kinase; has antineoplastic activity Bioactivity details MOA